Mucosal vaccination with enzymatically active Helicobacter pylori γ-glutamyl transferase (GGT) adjuvanted with STING-agonist elicits robust Th1/Th17 immunity in mice
Frontiers in Microbiology · 30.06.2026 · 17
DOI: 10.3389/fmicb.2026.1825914 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 30.06.2026. Verfasst von Monish Kumar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biomolecular Engineering, University of Houston, Houston, TX, United States. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, NCRR NIH HHS.
Abstract (Originalsprache)
Helicobacter pylori infection is the leading cause of chronic gastritis and a major risk factor for gastric cancer, yet no licensed vaccine is currently available. The H. pylori γ -glutamyl transferase (hpGGT) is a key virulence factor that contributes to bacterial colonization and persistence, making it a promising antigen for vaccine development. Although hpGGT has been reported to exert immunosuppressive effects through its enzymatic activity, whether the enzymatic activity affects its immunogenicity is unknown. To address this question, we intranasally immunized mice with recombinant wild-type hpGGT (WT-GGT) or a structurally similar, enzymatically inactive variant (In-GGT), each formulated with a liposomal STING-agonist adjuvant. Despite the potential for immunosuppression, the enzymatically active WT-GGT was the superior immunogen: it elicited robust Th1 and Th17 responses, along with strong gastric IgA production—immune features known to be critical for protection against H. pylori . These findings demonstrate that intranasal immunization with WT-GGT combined with a STING-agonist adjuvant induces mucosal and cellular immunity, supporting its potential as a viable vaccine strategy against H. pylori .
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Chemical and Biomolecular Engineering, University of Houston, Houston, TX, United States.
- Department of Biomedical Engineering, University of Houston, Houston, TX, United States.
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- NCRR NIH HHS
Zitieren
APA
Kumar, M., Li, J., & Varadarajan, N. (2026). Mucosal vaccination with enzymatically active Helicobacter pylori γ-glutamyl transferase (GGT) adjuvanted with STING-agonist elicits robust Th1/Th17 immunity in mice. Frontiers in Microbiology, 17. https://doi.org/10.3389/fmicb.2026.1825914
Vancouver
Kumar M, Li J, Varadarajan N. Mucosal vaccination with enzymatically active Helicobacter pylori γ-glutamyl transferase (GGT) adjuvanted with STING-agonist elicits robust Th1/Th17 immunity in mice. Frontiers in Microbiology. 2026;17. doi:10.3389/fmicb.2026.1825914
BibTeX
@article{Kumar2026,
author = {Kumar, Monish and Li, Jiayan and Varadarajan, Navin},
title = {Mucosal vaccination with enzymatically active Helicobacter pylori γ-glutamyl transferase (GGT) adjuvanted with STING-agonist elicits robust Th1/Th17 immunity in mice},
journal = {Frontiers in Microbiology},
year = {2026},
volume = {17},
doi = {10.3389/fmicb.2026.1825914}
}
EUVIMED